AbbVie (ABBV) Goodwill & Intangibles (2012 - 2026)

AbbVie (ABBV) posted quarterly Goodwill & Intangibles of $86.4 billion for Q1 2026, down 7.82% YoY from $93.8 billion in Q1 2025, and down 2.08% sequentially from $88.3 billion in Q4 2025.

AbbVie (ABBV) Goodwill & Intangibles (2012 - 2026) Analysis & Trends

AbbVie has disclosed Goodwill & Intangibles across 15 years of filings, most recently posting $86.4 billion for Q1 2026.

  • In Q1 2026, Goodwill & Intangibles fell 7.82% year-over-year to $86.4 billion; the TTM figure through Mar 2026 stood at $86.4 billion (down 7.82% YoY), while the FY2025 annual figure was $88.3 billion, down 7.1% from the prior year.
  • Goodwill & Intangibles slipped to $86.4 billion in Q1 2026, from $88.3 billion in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for ABBV reached as high as $106.3 billion in Q1 2022 and fell as low as $36.3 billion in Q3 2025.
  • The 5-year median for Goodwill & Intangibles is $95.0 billion (2024), against an average of $92.0 billion.
  • Annual changes were most pronounced in 2024 — Goodwill & Intangibles grew 12.4% — and 2025, when it plunged 64.35%.
  • A 5-year view of Goodwill & Intangibles shows it stood at $99.6 billion in 2022, then slipped by 11.74% to $87.9 billion in 2023, then rose by 8.1% to $95.0 billion in 2024, then slipped by 7.1% to $88.3 billion in 2025, then declined by 2.08% to $86.4 billion in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $86.4 billion, $88.3 billion, and $36.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.44 Bn
Dec 31, 2025 88.28 Bn
Sep 30, 2025 36.34 Bn
Jun 30, 2025 92.67 Bn
Mar 31, 2025 93.77 Bn
Dec 31, 2024 95.02 Bn
Sep 30, 2024 101.94 Bn
Jun 30, 2024 93.63 Bn
Mar 31, 2024 95.65 Bn
Dec 31, 2023 87.90 Bn
Sep 30, 2023 90.69 Bn
Jun 30, 2023 95.09 Bn
Mar 31, 2023 97.07 Bn
Dec 31, 2022 99.60 Bn
Sep 30, 2022 100.45 Bn
Jun 30, 2022 103.85 Bn
Mar 31, 2022 106.28 Bn
Dec 31, 2021 108.33 Bn
Sep 30, 2021 109.75 Bn
Jun 30, 2021 111.74 Bn